Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Invasive cervical cancers from women living in the United States or Botswana: differences in human papillomavirus type distribution.

Ermel A, Ramogola-Masire D, Zetola N, Tong Y, Qadadri B, Azar MM, Brown DR.

Infect Agent Cancer. 2014 Jul 8;9:22. doi: 10.1186/1750-9378-9-22. eCollection 2014 Jul 8.

2.

Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications.

Ermel A, Qadadri B, Tong Y, Orang'o O, Macharia B, Ramogola-Masire D, Zetola NM, Brown DR.

Infect Agent Cancer. 2016 Nov 11;11:56. eCollection 2016 Nov 11.

3.

Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.

Darwich L, Cañadas MP, Sirera G, Alameda F, Forcada P, Delas J, Fernández I, Llatjós M, Coll J, Clotet B, Videla S.

Int J Gynecol Cancer. 2011 Nov;21(8):1486-90. doi: 10.1097/IGC.0b013e31822a0195.

PMID:
21892092
4.

Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana.

Ramogola-Masire D, McGrath CM, Barnhart KT, Friedman HM, Zetola NM.

Int J Gynecol Pathol. 2011 Nov;30(6):591-6. doi: 10.1097/PGP.0b013e31821bf2a6.

5.

Oncogenic viral prevalence in invasive vulvar cancer specimens from human immunodeficiency virus-positive and -negative women in Botswana.

Tesfalul M, Simbiri K, Wheat CM, Motsepe D, Goldbach H, Armstrong K, Hudson K, Kayembe MK, Robertson E, Kovarik C.

Int J Gynecol Cancer. 2014 May;24(4):758-65. doi: 10.1097/IGC.0000000000000111.

6.

Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.

van Aardt MC, Dreyer G, Pienaar HF, Karlsen F, Hovland S, Richter KL, Becker P.

Int J Gynecol Cancer. 2015 Jun;25(5):919-25. doi: 10.1097/IGC.0000000000000422.

PMID:
25950128
7.

Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.

Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, Snyman L, Wiredu E, Molijn A, Quint W, Ramakrishnan G, Schmidt J.

Int J Cancer. 2014 Mar 15;134(6):1389-98. doi: 10.1002/ijc.28425. Epub 2013 Nov 14.

8.

Are the human papillomavirus genotypes different in cervical cancer and intraepithelial neoplasia in Jewish Israeli women, a low-risk population?

Laskov I, Grisaru D, Efrat G, Trejo LL, Grisaru G, Avidor B.

Int J Gynecol Cancer. 2013 May;23(4):730-4. doi: 10.1097/IGC.0b013e318288eee5.

PMID:
23446379
9.

HPV genotypes detected in cervical cancers from Alaska Native women, 1980-2007.

Kelly JJ, Unger ER, Dunne EF, Murphy NJ, Tiesinga J, Koller KR, Swango-Wilson A, Philemonof D, Lounmala X, Markowitz LE, Steinau M, Hennessy T.

Int J Circumpolar Health. 2013 Aug 5;72. doi: 10.3402/ijch.v72i0.21115. eCollection 2013 Aug 5.

10.

HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.

Hariri S, Steinau M, Rinas A, Gargano JW, Ludema C, Unger ER, Carter AL, Grant KL, Bamberg M, McDermott JE, Markowitz LE, Brewer NT, Smith JS.

PLoS One. 2012;7(3):e34044. doi: 10.1371/journal.pone.0034044. Epub 2012 Mar 29.

11.

Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana.

Macleod IJ, O'Donnell B, Moyo S, Lockman S, Shapiro RL, Kayembe M, van Widenfelt E, Makhema J, Essex M, Wester C.

J Med Virol. 2011 Oct;83(10):1689-95. doi: 10.1002/jmv.22178.

12.

Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.

ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, Mtiro H, Mhina M, Kashaija P, Ockert S, Yu X, et al.

Int J Cancer. 1992 Jun 19;51(4):515-21.

PMID:
1318265
13.

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.

Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE.

J Natl Cancer Inst. 2009 Apr 1;101(7):475-87. doi: 10.1093/jnci/djn510. Epub 2009 Mar 24.

14.

Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women.

Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, Fazzari M, Cu-Uvin S, Bacon M, Schuman P, Levine AM, Durante AJ, Gange S, Melnick S, Burk RD.

J Natl Cancer Inst. 2003 Jul 16;95(14):1062-71.

PMID:
12865452
15.

Type distribution of human papillomavirus among adult women diagnosed with invasive cervical cancer (stage 1b or higher) in New Zealand.

Sykes P, Gopala K, Tan AL, Kenwright D, Petrich S, Molijn A, Chen J.

BMC Infect Dis. 2014 Jul 8;14:374. doi: 10.1186/1471-2334-14-374.

16.

Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana.

Firnhaber C, Evans D, Friedman-Khalili R, Willliams S, Michelow P, Matlhagela K, Wester C, Grinsztejn B, Lockman S.

J Clin Virol. 2011 Nov;52(3):265-8. doi: 10.1016/j.jcv.2011.08.011. Epub 2011 Sep 9.

PMID:
21908233
17.

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX; Retrospective International Survey and HPV Time Trends Study Group..

Lancet Oncol. 2010 Nov;11(11):1048-56. doi: 10.1016/S1470-2045(10)70230-8. Epub 2010 Oct 15.

PMID:
20952254
18.

Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.

Sánchez-Lander J, Cortiñas P, Loureiro CL, Pujol FH, Medina F, Capote-Negrín L, Bianchi G, García-Barriola V, Ruiz-Benni A, Avilán-Rovira J, Acosta H.

Cancer Epidemiol. 2012 Oct;36(5):e284-7. doi: 10.1016/j.canep.2012.04.005. Epub 2012 May 17.

PMID:
22608058
19.

The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa.

Ng'andwe C, Lowe JJ, Richards PJ, Hause L, Wood C, Angeletti PC.

BMC Infect Dis. 2007 Jul 16;7:77.

20.

Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits.

Meiring TL, Salimo AT, Coetzee B, Maree HJ, Moodley J, Hitzeroth II, Freeborough MJ, Rybicki EP, Williamson AL.

Virol J. 2012 Aug 16;9:164. doi: 10.1186/1743-422X-9-164.

Supplemental Content

Support Center